相似文献
1
Biodegradable nanoparticles for cytosolic delivery of therapeutics.
Adv Drug Deliv Rev. 2007 Aug 10;59(8):718-28. doi: 10.1016/j.addr.2007.06.003. Epub 2007 Jun 26.
2
Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
J Mater Sci Mater Med. 2006 Jun;17(6):509-16. doi: 10.1007/s10856-006-8933-3.
3
Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
Eur J Pharm Biopharm. 2003 Nov;56(3):327-36. doi: 10.1016/s0939-6411(03)00096-1.
4
Protein instability in poly(lactic-co-glycolic acid) microparticles.
Pharm Res. 2000 Oct;17(10):1159-67. doi: 10.1023/a:1026498209874.
5
Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.
Pharm Res. 2012 Apr;29(4):932-42. doi: 10.1007/s11095-011-0633-0. Epub 2011 Dec 3.
6
Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
Pharm Res. 1999 Jul;16(7):1114-8. doi: 10.1023/a:1018908421434.
7
Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Biomaterials. 1997 Sep;18(17):1147-52. doi: 10.1016/s0142-9612(97)00052-5.
8
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47. doi: 10.1016/s0169-409x(02)00228-4.
9
Concepts and practices used to develop functional PLGA-based nanoparticulate systems.
Int J Nanomedicine. 2013;8:747-65. doi: 10.2147/IJN.S40579. Epub 2013 Feb 21.
10
Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Int J Pharm. 2013 Mar 25;446(1-2):24-33. doi: 10.1016/j.ijpharm.2013.02.004. Epub 2013 Feb 10.
引用本文的文献
1
Aptamer-Coated PLGA Nanoparticles Selectively Internalize into Epithelial Ovarian Cancer Cells In Vitro and In Vivo.
Biomolecules. 2025 Aug 4;15(8):1123. doi: 10.3390/biom15081123.
2
Squalene in Nanoparticles Improves Antiproliferative Effect on Human Colon Carcinoma Cells Through Apoptosis by Disturbances in Redox Balance.
Int J Mol Sci. 2024 Dec 4;25(23):13048. doi: 10.3390/ijms252313048.
3
Nanospheres as the delivery vehicle: novel application of ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis.
Front Immunol. 2024 Oct 1;15:1475280. doi: 10.3389/fimmu.2024.1475280. eCollection 2024.
4
Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment.
Curr Top Med Chem. 2025;25(3):243-262. doi: 10.2174/0115680266299112240514103048.
5
From Polymeric Nanoformulations to Polyphenols-Strategies for Enhancing the Efficacy and Drug Delivery of Gentamicin.
Antibiotics (Basel). 2024 Mar 28;13(4):305. doi: 10.3390/antibiotics13040305.
6
Development of high-efficiency superparamagnetic drug delivery system with MPI imaging capability.
Front Bioeng Biotechnol. 2024 Mar 20;12:1382085. doi: 10.3389/fbioe.2024.1382085. eCollection 2024.
7
Rejuvenating aged microglia by p16-siRNA-loaded nanoparticles increases amyloid-β clearance in animal models of Alzheimer's disease.
Mol Neurodegener. 2024 Mar 16;19(1):25. doi: 10.1186/s13024-024-00715-x.
8
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy.
Drug Deliv Transl Res. 2024 Oct;14(10):2788-2803. doi: 10.1007/s13346-024-01557-2. Epub 2024 Mar 1.
9
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer.
ACS Biomater Sci Eng. 2024 Mar 11;10(3):1355-1363. doi: 10.1021/acsbiomaterials.4c00160. Epub 2024 Feb 2.
10
Mineralized Collagen/Polylactic Acid Composite Scaffolds for Load-Bearing Bone Regeneration in a Developmental Model.
Polymers (Basel). 2023 Oct 23;15(20):4194. doi: 10.3390/polym15204194.
本文引用的文献
1
Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.
J Neurol Sci. 2006 May 15;244(1-2):151-8. doi: 10.1016/j.jns.2006.02.006. Epub 2006 Mar 6.
2
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene.
J Control Release. 2006 May 15;112(2):229-39. doi: 10.1016/j.jconrel.2006.01.022. Epub 2006 Mar 20.
3
Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors.
Bioconjug Chem. 2006 Jan-Feb;17(1):90-100. doi: 10.1021/bc050274h.
4
Targeting intracellular targets.
Curr Drug Deliv. 2004 Jul;1(3):235-47. doi: 10.2174/1567201043334768.
5
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI.
J Control Release. 2005 Dec 5;109(1-3):299-316. doi: 10.1016/j.jconrel.2005.09.036. Epub 2005 Nov 17.
6
Intelligent polymers as nonviral vectors.
Gene Ther. 2005 Oct;12 Suppl 1:S139-45. doi: 10.1038/sj.gt.3302628.
7
Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.
Mol Pharm. 2005 Sep-Oct;2(5):373-83. doi: 10.1021/mp050032z.
8
Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
J Cell Sci. 2005 Aug 1;118(Pt 15):3339-51. doi: 10.1242/jcs.02460.
9
Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells.
Mol Pharm. 2004 May-Jun;1(3):211-9. doi: 10.1021/mp049970+.
10
Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: a rational gene therapy for primary hyperoxaluria-1 (PH-1).
Am J Nephrol. 2005 Mar-Apr;25(2):176-82. doi: 10.1159/000085410. Epub 2005 Apr 21.
Zotero 插件